Skip to main content

Operative Outcomes of Metabolic/Bariatric Surgery in Subjects with Type 1 Obesity Index (30–35 kg/m2)

  • Chapter
  • First Online:
The ASMBS Textbook of Bariatric Surgery

Abstract

The body mass index (BMI) was developed as an objective and easy method to measure obesity, and it became a useful tool for population and epidemiological studies. BMI was quickly adopted as the main criterion for bariatric surgery, with a “cutoff” value of 35–40 kg/m2, depending on the patients’ comorbidities. However, by ignoring other parameters such as race, gender, age, and fat distribution, this arbitrary system excluded many patients who could benefit from this lifesaving treatment. In addition, there is increasing evidence that bariatric/metabolic surgery in patients with BMI from 30 kg/m2 may have a positive effect on medically uncontrolled type 2 diabetes mellitus (T2DM) as well as other comorbidities. Hence, this provides a strong argument for performing bariatric/metabolic surgery in patients with lower BMI. This chapter identifies the main pitfalls of the present BMI-centered inclusion criteria for bariatric surgery, justifies the need for bariatric/metabolic surgery in patients regardless of baseline BMI, and determines the efficacy and safety of bariatric procedures in those patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pories WJ, Dohm LG, Mansfield CJ. Beyond the BMI: the search for better guidelines for bariatric surgery. Obesity. 2010;18(5):865–71.

    Article  Google Scholar 

  2. Rubino F, Nathan DM, Eckel RH, et al. Delegates of the 2nd diabetes surgery summit. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39:861–77.

    Article  CAS  Google Scholar 

  3. American Diabetes Association Standards of Medical Care in Diabetes. Diabetes Care. 2017;40(Suppl. 1):S1–2.

    Google Scholar 

  4. Batterham RL, Cummings D. Mechanisms of diabetes improvement following bariatric/metabolic surgery. Diabetes Care. 2016;39(6):893–901.

    Article  Google Scholar 

  5. Sjostrom L. Review of the key results from the Swedish obese subjects (SOS) trial – a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–34.

    Article  CAS  Google Scholar 

  6. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012. 2012;366:1577–85.

    Article  CAS  Google Scholar 

  7. le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2006;243(1):108–14. https://doi.org/10.1097/01.sla.0000183349.16877.84.

    Article  PubMed  Google Scholar 

  8. Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes. A randomized controlled trial. JAMA. 2008;299(3):316–23.

    Article  CAS  Google Scholar 

  9. Himpens J, Dapri G, Cadiere GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg. 2006;16(11):1450–6.

    Article  Google Scholar 

  10. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–76.

    Article  CAS  Google Scholar 

  11. Peterli R, Wölnerhanssen BK, Peters T, Vetter D, Kröll D, Borbély Y, Schultes B, Beglinger C, Drewe J, Schiesser M, Nett P, Bueter M. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319(3):255–65.

    Article  Google Scholar 

  12. Ma J, Vella A. What has bariatric surgery taught us about the role of the upper gastrointestinal tract in the regulation of postprandial glucose metabolism? Front Endocrinol. 2018;9:article 324.

    Article  Google Scholar 

  13. Jackness C, Karmally W, Febres G, et al. Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and β-cell function in type 2 diabetic patients. Diabetes. 2013;62(9):3027–32. https://doi.org/10.2337/db12-1762.

    Article  CAS  PubMed  Google Scholar 

  14. Lee WJ, Ser KH, Chong K, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery. 2010;147(5):664–9.

    Article  Google Scholar 

  15. Lee WJ, Hur KY, Lakadawala M, et al. Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study. J Gastrointest Surg. 2012;16:45–52.

    Article  Google Scholar 

  16. Abbatini F, Capoccia D, Casella G, et al. Type 2 diabetes in obese patients with body mass index of 30-35 kg/m2: sleeve gastrectomy versus medical treatment. Surg Obes Relat Dis. 2012;8:20–4.

    Article  Google Scholar 

  17. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery vs. intensive medical for diabetes – 5 year outcomes. N Engl J Med. 2017;376:641–51.

    Article  Google Scholar 

  18. Chiellini C, Rubino F, Castagneto M, et al. The effect of bilio-pancreatic diversion on type 2 diabetes in patients with BMI < 35 kg/m2. Diabetologia. 2009;52:1027–30.

    Article  CAS  Google Scholar 

  19. Scopinaro N, Adami GF, Papadia FS, et al. The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30–35 kg/m2) and simple overweight (BMI 25–30 kg/m2): a prospective controlled study. Obes Surg. 2011;21:880.

    Article  Google Scholar 

  20. Cohen R, Pinheiro JS, Correa JL, Schiavon CA, et al. Laparoscopic Roux-en-Y gastric bypass for BMI < 35 kg/m(2): a tailored approach. Surg Obes Relat Dis. 2006;2(3):401–4.

    Article  Google Scholar 

  21. Cohen R, Pinheiro JS, Schiavon C, et al. Effect of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care. 2012;35(7):1420–8.

    Article  Google Scholar 

  22. Lee WJ, Chong K, Chen CY, et al. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index < 35kg/m2. Obes Surg. 2011;21:889–95.

    Article  Google Scholar 

  23. Shah SS, Todkar JS, Shah PS, et al. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index < 35 kg/m2. Surg Obes Relat Dis. 2010;6(4):332–8.

    Article  Google Scholar 

  24. Ikramuddin S, Korner J, Lee WJ, et al. Lifestyle intervention and medical management with vs without Roux-en-Y gastric bypass and control of hemoglobin A1c, LDL cholesterol, and systolic blood pressure at 5 years in the diabetes surgery study. JAMA. 2018;319(3):266–78.

    Article  Google Scholar 

  25. Aminian A, Andalib A, Khorgami Z, et al. A nationwide safety analysis of bariatric surgery in nonseverely obese patients with type 2 diabetes. Surg Obes Relat Dis. 2016;12(6):1163–70.

    Article  Google Scholar 

  26. Cohen RV, Le Roux C, Junqueira S, et al. Roux-En-Y gastric bypass in type 2 diabetes patients with mild obesity: a systematic review and meta-analysis. Obes Surg. 2017;27:2733–9.

    Article  Google Scholar 

  27. Panunzi S, De Gaetano A, Carnicelli A, Mingrone G. Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis. Ann Surg. 2015;261:459–67.

    Article  Google Scholar 

  28. Tinoco A, El-Kadre L, Aquiar L, et al. Short-term and mid-term control of type 2 diabetes mellitus by laparoscopic sleeve gastrectomy with ileal interposition. World J Surg. 2011;35(10):2238–44.

    Article  Google Scholar 

  29. Kota SK, Ugale S, Gupta N, et al. Ileal interposition with sleeve gastrectomy for treatment of type 2 diabetes mellitus. Indian J Endocrinol Metab. 2012;16(4):589–98.

    Article  CAS  Google Scholar 

  30. Kota SK, Ugale S, Gupta N, Modi KD. Laparoscopic ileal interposition with diverted sleeve gastrectomy for treatment of type 2 diabetes. Diabetes Metab Syndr. 2012;6(3):125–31.

    Article  Google Scholar 

  31. DePaula AL, Stival AR, Halpern A, Vencio S. Surgical treatment of morbid obesity: mid-term outcomes of the laparoscopic Ileal interposition associated to a sleeve gastrectomy in 120 patients. Obes Surg. 2010;21(5):668–75.

    Article  Google Scholar 

  32. Cohen R, Caravatto PP, Correa JL, et al. Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index. SOARD. 2012;8(4):375–80.

    Google Scholar 

  33. Geloneze B, Geloneze SR, Fiori C, et al. Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion. Obes Surg. 2009;19(8):1077–83.

    Article  Google Scholar 

  34. Ramos AC, Neto MG, de Souza YM, Galvão M. Laparoscopic duodenal–jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI. Obes Surg 2009 <30 kg/m2 (LBMI). 19(3):307–12.

    Google Scholar 

  35. Petry TZ, Frabbrini E, Otoch JP. Effect of duodenal–Jejunal bypass surgery on glycemic control in type 2 diabetes: a randomized controlled trial. Obesity. 2015;23(10):1973–9.

    Article  CAS  Google Scholar 

  36. Seki Y, Kasama K, Yasuda K, et al. The effects of laparoscopic sleeve gastrectomy with duodenojejunal bypass on Japanese patients with BMI < 35 kg/m2 on type 2 diabetes mellitus and the prediction of successful glycemic control. Obes Surg. 2018;28:242938.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ricardo V. Cohen .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cohen, R.V., Petry, T.Z., Negri, E.A. (2020). Operative Outcomes of Metabolic/Bariatric Surgery in Subjects with Type 1 Obesity Index (30–35 kg/m2). In: Nguyen, N., Brethauer, S., Morton, J., Ponce, J., Rosenthal, R. (eds) The ASMBS Textbook of Bariatric Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-27021-6_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-27021-6_32

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-27020-9

  • Online ISBN: 978-3-030-27021-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics